These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 20346613)

  • 1. [Pathophysiology of restless legs syndrome].
    Monaca C
    Presse Med; 2010 May; 39(5):587-91. PubMed ID: 20346613
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Restless legs syndrome: revisiting the dopamine hypothesis from the spinal cord perspective.
    Clemens S; Rye D; Hochman S
    Neurology; 2006 Jul; 67(1):125-30. PubMed ID: 16832090
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Pathophysiology of restless legs syndrome].
    Miyamoto M; Miyamoto T; Iwanami M; Suzuki K; Hirata K
    Brain Nerve; 2009 May; 61(5):523-32. PubMed ID: 19514512
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Changes of cortical excitability after dopaminergic treatment in restless legs syndrome.
    Scalise A; Pittaro-Cadore I; Janes F; Marinig R; Gigli GL
    Sleep Med; 2010 Jan; 11(1):75-81. PubMed ID: 19595629
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dopamine and the spinal cord in restless legs syndrome: does spinal cord physiology reveal a basis for augmentation?
    Paulus W; Schomburg ED
    Sleep Med Rev; 2006 Jun; 10(3):185-96. PubMed ID: 16762808
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dopaminergic augmentation of restless legs syndrome.
    García-Borreguero D; Williams AM
    Sleep Med Rev; 2010 Oct; 14(5):339-46. PubMed ID: 20219397
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Spinal cord dopamine receptor expression and function in mice with 6-OHDA lesion of the A11 nucleus and dietary iron deprivation.
    Zhao H; Zhu W; Pan T; Xie W; Zhang A; Ondo WG; Le W
    J Neurosci Res; 2007 Apr; 85(5):1065-76. PubMed ID: 17342757
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Iron, dopamine, genetics, and hormones in the pathophysiology of restless legs syndrome.
    Khan FH; Ahlberg CD; Chow CA; Shah DR; Koo BB
    J Neurol; 2017 Aug; 264(8):1634-1641. PubMed ID: 28236139
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dopamine and iron in the pathophysiology of restless legs syndrome (RLS).
    Allen R
    Sleep Med; 2004 Jul; 5(4):385-91. PubMed ID: 15222997
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Restless legs syndrome in 2004.
    Sonka K; Kemlink D
    Prague Med Rep; 2004; 105(4):337-56. PubMed ID: 15822631
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New Insights into the Neurobiology of Restless Legs Syndrome.
    Ferré S; García-Borreguero D; Allen RP; Earley CJ
    Neuroscientist; 2019 Apr; 25(2):113-125. PubMed ID: 30047288
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Less is more: pathophysiology of dopaminergic-therapy-related augmentation in restless legs syndrome.
    Paulus W; Trenkwalder C
    Lancet Neurol; 2006 Oct; 5(10):878-86. PubMed ID: 16987735
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical correlates of 6-hydroxydopamine injections into A11 dopaminergic neurons in rats: a possible model for restless legs syndrome.
    Ondo WG; He Y; Rajasekaran S; Le WD
    Mov Disord; 2000 Jan; 15(1):154-8. PubMed ID: 10634257
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Restless legs syndrome: update on pathogenesis.
    Dauvilliers Y; Winkelmann J
    Curr Opin Pulm Med; 2013 Nov; 19(6):594-600. PubMed ID: 24048084
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Restless legs: recent advances in basic research and therapy].
    Sieb JP
    Med Monatsschr Pharm; 2010 Apr; 33(4):133-9. PubMed ID: 20429403
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Altered brain iron homeostasis and dopaminergic function in Restless Legs Syndrome (Willis-Ekbom Disease).
    Earley CJ; Connor J; Garcia-Borreguero D; Jenner P; Winkelman J; Zee PC; Allen R
    Sleep Med; 2014 Nov; 15(11):1288-301. PubMed ID: 25201131
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Restless legs syndrome: pathophysiology, clinical presentation and management.
    Trenkwalder C; Paulus W
    Nat Rev Neurol; 2010 Jun; 6(6):337-46. PubMed ID: 20531433
    [TBL] [Abstract][Full Text] [Related]  

  • 18. What treatment works best for restless legs syndrome? Meta-analyses of dopaminergic and non-dopaminergic medications.
    Hornyak M; Scholz H; Kohnen R; Bengel J; Kassubek J; Trenkwalder C
    Sleep Med Rev; 2014 Apr; 18(2):153-64. PubMed ID: 23746768
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Restless Leg Syndrome/Willis-Ekbom Disease Pathophysiology.
    Allen RP
    Sleep Med Clin; 2015 Sep; 10(3):207-14, xi. PubMed ID: 26329430
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In restless legs syndrome, during changes in vigilance, the forced EEG shifts from alpha activity to delta or high alpha may lead to the altered states of dopamine receptor function and the symptoms.
    Akpinar S; Aydin H; Kutukcu Y
    Med Hypotheses; 2007; 69(2):273-81. PubMed ID: 17320307
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.